Skip to main content

Advertisement

Table 4 Distribution of 145 pathogens in 138 laboratory-confirmed BSIs

From: Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland

Isolate No of Isolates (n = 145)
CoNS (of these: methicillin-resistant) 50 (MRSE: 19)
Escherichia coli 22
α-hemolytic streptococci (Str. viridans) 21
Klebsiella pneumoniae 9
Pseudomonas aeruginosa 8
Staphylococcus aureus* 5
Enterobacter cloacae 4
Enterococcus spp. 3
Acinetobacter woffii 2
Bacillus spp. 2
Micrococcus spp. 2
Neisseria spp 2
Pantoea agglomerans 2
Vancomycin-resistant Enterococcus faecium (VRE) 2
Arthrobacter spp. 1
Burkholderia cepacia 1
Strep. Pneumoniae 1
Corynebacterium spp. 1
Kocuria kristinae 1
Leuconostoc spp. 1
MR-Klebsiella spp. 1
MR-Pseudomonas spp. 1
Proteus spp. 1
Ralstonia pickettii 1
Candida albicans 1
  1. BSI = bloodstream infection
  2. CoNS = coagulase-negative Staphylococci
  3. MRSE = methicillin-resistant coagulase-negative Staphylococci
  4. MR = multiresistant in vitro
  5. (here: to piperacillin, aminogylcosides and to 3rd generation cephalosporines)
  6. * No MRSA was detected.